31
total announcements
FORTIS.NS · 15 min delayed
Fortis Healthcare Limited
Fortis Healthcare Limited has made available the audio recording of its Investors/Analysts Meet held on September 4, 2026, on its website.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about the schedule of an upcoming investor meeting with the management to provide an update on recent developments.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange that a single judge bench of the Hon'ble Delhi High Court has passed an order dated August 31, 2026, in relation to certain applications filed by Daiichi Sankyo Company, Limited against the Company. The Court has directed the appointment of a forensic auditor to investigate the dissipation of the shareholding of the Singh Brothers, the subsequent change in control of the Company, and the role of relevant stakeholders. The Company was neither a party to the original dispute nor a judgment debtor in the execution proceedings, and the Court has not imposed any liability, penalty, or fine on the Company.
Fortis Healthcare Limited
Fortis Healthcare Limited has received an ESG rating of 'Crisil ESG 66' and 'Crisil Core ESG 72' from Crisil ESG Ratings & Analytics Ltd for the financial year 2025-26.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about Transcript of Investors / Analyst’s meet under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company reported consolidated revenue of INR 2,545 crores, a growth of 17.5% over Q1 of financial year '26. The hospital business revenues have grown by 19% to INR 2,187 crores while Q1 financial year '27 diagnostic business gross revenue has grown up by 10.2% to INR 407 crores.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about Shareholders meeting, submitting voting results along with consolidated Scrutinizer Report of 30th Annual General Meeting under Regulation 44 of SEBI Listing and Disclosure Requirements Regulations, 2015.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on August 11, 2026. The meeting was held through Video Conferencing/ Other Audio Visual Means (VC/OAVM) and was attended by the Chairman, Directors, and Key Managerial Personnel. The meeting considered and adopted the Audited Financial Statements for the financial year ended March 31, 2026, and declared a final dividend of Rs. 1/- (Rupee One) per equity share. Other resolutions related to the appointment of Directors, remuneration to Cost Auditors, and payment of commission to Independent Directors were also approved.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about Copy of Newspaper Publication regarding Un-Audited Financial Results for the quarter ended on June 30, 2026.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about the link of recording of an investors/analysts meet held on August 07, 2026, to discuss the company's unaudited financial results for the quarter ended June 30, 2026.
Fortis Healthcare Limited
Fortis Healthcare Limited has released its Q1 FY27 earnings presentation, highlighting a consolidated revenue of 2,545 crores, consolidated operating EBITDA of 568 crores, and consolidated PBT of 354 crores. The company's net debt to EBITDA ratio has improved to 1.01x from 0.92x.
Fortis Healthcare Limited
Fortis Healthcare Limited has announced its unaudited consolidated financial results for the quarter ended June 30, 2026, with consolidated revenues at INR 2,545 Cr, up 17.5%, and operating EBITDA margin at 22.3%. The company's hospital business revenues grew 19.0% and operating EBITDA margin was 21.5%. The company has also announced its entry into a new market in Odisha and plans to expand its presence in key clusters.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about the appointment of Tax Auditors, M/s. B S R & Co. LLP, for the Financial Year 2025-26.
Fortis Healthcare Limited
Fortis Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also appointed B S R & Co. LLP as its tax auditors for the financial year 2025-26.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about General Updates regarding an intra-group restructuring involving merger of its wholly owned subsidiaries - Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs Limited into Agilus Diagnostics Limited.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about the schedule of an investor meet and conference call to discuss the company's unaudited Q1FY27 financial results.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about the schedule of an upcoming conference call to discuss the Company’s unaudited Q1FY27 financial results.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange regarding 'Intimation on Tax Deduction at Source (TDS) / withholding tax on Dividend'. The company has recommended a final dividend of Rs. 1 per equity share for the financial year ended March 31, 2026, subject to the approval of the shareholders at the 30th Annual General Meeting scheduled to be held on August 11, 2026.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange regarding the appointment of Mr. Vijender Singh as Managing Director & Chief Executive Officer of Agilus Diagnostics Limited, a subsidiary of the Company.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange about the dispatch of 30th Annual General Meeting (AGM) notice and Annual Report for the financial year 2025-26 through video conferencing.
Fortis Healthcare Limited
Fortis Healthcare Limited has informed the Exchange regarding 'closure of Register of Members' and fixed the record date for the purpose of payment of final dividend for the financial year 2025-26 as Friday, July 24, 2026.